We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPureTech Regulatory News (PRTC)

Share Price Information for PureTech (PRTC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 218.00
Bid: 215.00
Ask: 217.50
Change: 5.50 (2.59%)
Spread: 2.50 (1.163%)
Open: 219.50
High: 219.50
Low: 207.00
Prev. Close: 212.50
PRTC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

9 Jan 2024 07:00

RNS Number : 0132Z
PureTech Health PLC
09 January 2024
 

9 January 2024

 

PureTech Health plc

 

Transaction in Own Shares

 

PureTech Health PLC (the "Company") announces that it has purchased the following number of its ordinary shares of one pence each through Jefferies International Limited ("Jefferies"), as part of its Share Buyback Programme, details of which were announced on 9 May 2022.

 

Date of purchase:

8 January 2024

Number of ordinary shares purchased:

26,079

Highest price paid per share:

207.50p

Lowest price paid per share:

204.00p

Volume weighted average price paid per share:

206.97p

 

PureTech intends to retain the purchased shares in treasury.

Following the above transaction, the Company will have 17,878,951 ordinary shares in treasury and has 271,589,208 ordinary shares in issue (excluding treasury shares). The total number of voting rights in the Company is therefore 271,589,208 which may be used by shareholders in their calculations to determine if they are required to notify their interest in, or a change to their interest in, PureTech Health plc under the FCA's Disclosure Guidance and Transparency Rules.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) (the Market Abuse Regulation), detailed information about the individual purchases is available below.

 

About PureTech Health

PureTech is a clinical-stage biotherapeutics company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases. The Company has created a broad and deep pipeline through its experienced research and development team and its extensive network of scientists, clinicians and industry leaders that is being advanced both internally and through its Founded Entities. PureTech's R&D engine has resulted in the development of 27 therapeutics and therapeutic candidates, including two (Plenity® and EndeavorRx®) that have received both U.S. FDA clearance and European marketing authorization and a third (KarXT) that has been filed for FDA approval. A number of these programs are being advanced by PureTech or its Founded Entities in various indications and stages of clinical development, including registration enabling studies. All of the underlying programs and platforms that resulted in this pipeline of therapeutic candidates were initially identified or discovered and then advanced by the PureTech team through key validation points.

 

For more information, visit www.puretechhealth.com or connect with us on X, formerly known as Twitter, @puretechh.

 

Contact:

PureTech

Investor Relations

IR@puretechhealth.com

Individual Transactions

 

Transaction Date

Transaction Time

Volume

Price (GBp)

Platform

Transaction Reference Number

08/01/2024

08:14:57

940

207.5

CHIX

00384448243TRLO0.1.1

08/01/2024

08:17:03

447

207

BATE

00384448722TRLO0.1.1

08/01/2024

08:17:03

527

207

AQXE

00384448721TRLO0.1.1

08/01/2024

08:17:03

247

207

TRQX

00384448723TRLO0.1.1

08/01/2024

08:17:03

23

207

BATE

00384448724TRLO0.1.1

08/01/2024

08:17:03

940

207

XLON

00384448725TRLO0.1.1

08/01/2024

08:22:08

438

204.5

XLON

00384449832TRLO0.1.1

08/01/2024

08:22:08

32

204.5

XLON

00384449833TRLO0.1.1

08/01/2024

08:32:05

470

204

XLON

00384452038TRLO0.1.1

08/01/2024

08:32:05

470

204

XLON

00384452039TRLO0.1.1

08/01/2024

08:32:05

30

204

XLON

00384452040TRLO0.1.1

08/01/2024

08:32:05

70

204

XLON

00384452041TRLO0.1.1

08/01/2024

08:32:05

370

204

XLON

00384452042TRLO0.1.1

08/01/2024

08:32:05

115

204

XLON

00384452043TRLO0.1.1

08/01/2024

08:32:05

355

204

XLON

00384452044TRLO0.1.1

08/01/2024

09:01:49

337

207.5

AQXE

00384456705TRLO0.1.1

08/01/2024

09:01:49

52

207.5

BATE

00384456706TRLO0.1.1

08/01/2024

09:01:49

500

207.5

XLON

00384456707TRLO0.1.1

08/01/2024

09:01:49

232

207.5

CHIX

00384456709TRLO0.1.1

08/01/2024

09:01:49

910

207.5

XLON

00384456708TRLO0.1.1

08/01/2024

09:01:49

238

207.5

CHIX

00384456710TRLO0.1.1

08/01/2024

09:01:49

35

207.5

BATE

00384456711TRLO0.1.1

08/01/2024

09:01:49

40

207.5

BATE

00384456712TRLO0.1.1

08/01/2024

09:01:49

343

207.5

BATE

00384456713TRLO0.1.1

08/01/2024

09:03:51

247

207

TRQX

00384456990TRLO0.1.1

08/01/2024

09:29:34

470

206

XLON

00384461485TRLO0.1.1

08/01/2024

09:29:34

158

206

XLON

00384461486TRLO0.1.1

08/01/2024

09:29:34

312

206

XLON

00384461487TRLO0.1.1

08/01/2024

09:29:34

3

206

XLON

00384461488TRLO0.1.1

08/01/2024

09:29:34

416

206

XLON

00384461490TRLO0.1.1

08/01/2024

09:29:34

51

206

XLON

00384461489TRLO0.1.1

08/01/2024

09:29:34

83

206

XLON

00384461491TRLO0.1.1

08/01/2024

09:29:34

387

206

XLON

00384461492TRLO0.1.1

08/01/2024

09:48:50

470

206.5

CHIX

00384465335TRLO0.1.1

08/01/2024

10:03:48

125

207

XLON

00384467922TRLO0.1.1

08/01/2024

10:04:23

66

207

XLON

00384467995TRLO0.1.1

08/01/2024

10:05:19

54

207

XLON

00384468106TRLO0.1.1

08/01/2024

10:05:39

25

207

XLON

00384468140TRLO0.1.1

08/01/2024

10:06:15

36

207

XLON

00384468218TRLO0.1.1

08/01/2024

10:50:34

1430

207.5

XLON

00384475873TRLO0.1.1

08/01/2024

10:50:34

1675

207.5

XLON

00384475874TRLO0.1.1

08/01/2024

10:50:34

349

207.5

XLON

00384475875TRLO0.1.1

08/01/2024

10:50:42

300

207

CHIX

00384475901TRLO0.1.1

08/01/2024

11:29:51

247

207.5

TRQX

00384481501TRLO0.1.1

08/01/2024

11:29:51

170

207

CHIX

00384481502TRLO0.1.1

08/01/2024

11:29:51

55

207

CHIX

00384481505TRLO0.1.1

08/01/2024

12:59:44

58

207.5

TRQX

00384494199TRLO0.1.1

08/01/2024

12:59:55

415

207.5

CHIX

00384494224TRLO0.1.1

08/01/2024

12:59:55

432

207.5

AQXE

00384494223TRLO0.1.1

08/01/2024

12:59:55

470

207.5

BATE

00384494225TRLO0.1.1

08/01/2024

12:59:55

189

207.5

TRQX

00384494226TRLO0.1.1

08/01/2024

12:59:55

940

207.5

XLON

00384494227TRLO0.1.1

08/01/2024

13:18:52

470

207

XLON

00384496972TRLO0.1.1

08/01/2024

13:18:52

67

207

XLON

00384496973TRLO0.1.1

08/01/2024

13:18:52

234

207

XLON

00384496975TRLO0.1.1

08/01/2024

13:18:52

403

207

XLON

00384496974TRLO0.1.1

08/01/2024

13:18:52

236

207

XLON

00384496976TRLO0.1.1

08/01/2024

13:18:52

30

207

XLON

00384496977TRLO0.1.1

08/01/2024

13:18:52

440

207

XLON

00384496978TRLO0.1.1

08/01/2024

15:51:30

470

207.5

BATE

00384553027TRLO0.1.1

08/01/2024

15:51:30

30

207.5

BATE

00384553028TRLO0.1.1

08/01/2024

15:56:08

432

207.5

AQXE

00384555512TRLO0.1.1

08/01/2024

15:58:17

2

207.5

XLON

00384556616TRLO0.1.1

08/01/2024

15:58:17

468

207.5

XLON

00384556617TRLO0.1.1

08/01/2024

15:58:17

470

207.5

XLON

00384556618TRLO0.1.1

08/01/2024

15:58:17

507

207.5

XLON

00384556619TRLO0.1.1

08/01/2024

15:58:17

433

207.5

XLON

00384556620TRLO0.1.1

08/01/2024

15:58:17

470

207.5

XLON

00384556621TRLO0.1.1

08/01/2024

15:58:17

470

207.5

XLON

00384556622TRLO0.1.1

08/01/2024

15:58:17

470

207.5

XLON

00384556623TRLO0.1.1

08/01/2024

15:58:17

470

207.5

XLON

00384556625TRLO0.1.1

08/01/2024

15:58:17

470

207.5

XLON

00384556624TRLO0.1.1

08/01/2024

15:58:17

390

207.5

XLON

00384556626TRLO0.1.1

08/01/2024

15:58:17

550

207.5

XLON

00384556627TRLO0.1.1

08/01/2024

15:58:17

303

207.5

XLON

00384556628TRLO0.1.1

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFLFVTLAITIIS
Date   Source Headline
25th Apr 20247:00 amRNSFinal Results
18th Apr 20247:00 amRNSNotice of Results
16th Apr 202412:00 pmRNSPRTC LYT-100 Ph2b in IPF Enrolled; Results Q4 2024
11th Apr 202412:00 pmRNSFDA Grants PRTC's LYT-200 Fast Track Designation
9th Apr 20247:00 amRNSPRTC Launches Seaport w/ $100M; Leadership Changes
19th Mar 20247:00 amRNS$100M Tender Offer
18th Mar 20241:32 pmRNS$14B Acquisition of PRTC’s Karuna by BMS Completed
13th Mar 202411:00 amRNSFDA Grants PRTC's LYT-200 Orphan Drug Designation
6th Mar 20247:00 amRNSPDMR Notification RSU Vesting
27th Feb 202412:00 pmRNSPRTC to Present at Cowen and Leerink Conferences
27th Feb 20247:00 amRNSPRTC: Akili Positive Ph3 & Japan PMDA Submission
8th Feb 20247:00 amRNSTransaction in Own Shares
7th Feb 20247:00 amRNSTransaction in Own Shares
6th Feb 20247:00 amRNSTransaction in Own Shares
5th Feb 20247:00 amRNSTransaction in Own Shares
2nd Feb 20247:00 amRNSTransaction in Own Shares
1st Feb 20247:00 amRNSTransaction in Own Shares
31st Jan 20247:00 amRNSTransaction in Own Shares
30th Jan 20247:00 amRNSTransaction in Own Shares
29th Jan 20245:30 pmRNSTransaction in Own Shares
26th Jan 20247:00 amRNSTransaction in Own Shares
25th Jan 20247:00 amRNSTransaction in Own Shares
24th Jan 20247:00 amRNSTransaction in Own Shares
23rd Jan 20247:00 amRNSTransaction in Own Shares
22nd Jan 20247:00 amRNSTransaction in Own Shares
19th Jan 20247:00 amRNSTransaction in Own Shares
18th Jan 20247:00 amRNSTransaction in Own Shares
17th Jan 20247:00 amRNSTransaction in Own Shares
16th Jan 20247:00 amRNSTransaction in Own Shares
15th Jan 20247:00 amRNSTransaction in Own Shares
12th Jan 20247:00 amRNSTransaction in Own Shares
11th Jan 20247:00 amRNSTransaction in Own Shares
10th Jan 20247:00 amRNSTransaction in Own Shares
9th Jan 20247:00 amRNSTransaction in Own Shares
8th Jan 20247:00 amRNSTransaction in Own Shares
5th Jan 20247:00 amRNSTransaction in Own Shares
4th Jan 20247:00 amRNSTransaction in Own Shares
3rd Jan 202412:00 pmRNSPureTech to present at the JP Morgan Conference
3rd Jan 20247:00 amRNSTransaction in Own Shares
27th Dec 20237:00 amRNSTransaction in Own Shares
22nd Dec 20231:31 pmRNSBMY Acquires PRTC Founded Entity Karuna for $14B
22nd Dec 20237:00 amRNSTransaction in Own Shares
21st Dec 20237:00 amRNSTransaction in Own Shares
20th Dec 20237:00 amRNSPRTC Year End Update & Outlook for 2024
20th Dec 20237:00 amRNSTransaction in Own Shares
19th Dec 20237:00 amRNSTransaction in Own Shares
18th Dec 20237:00 amRNSTransaction in Own Shares
15th Dec 20237:00 amRNSTransaction in Own Shares
14th Dec 20237:00 amRNSTransaction in Own Shares
13th Dec 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.